Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

GNPS - Advanced Marfey's analysis of rivulariapeptolides

ABSTRACT: Ahp-cyclodepsipeptides (rivulariapeptolides) were subjected to PDC oxidation, hydrolysis, and subsequent advanced marfey's analysis.

INSTRUMENT(S): Q Exactive HF

ORGANISM(S): Rivularia (ncbitaxon:373984)

SUBMITTER: Daniel Petras

PROVIDER: MSV000088578 | GNPS | Fri Dec 17 01:32:00 GMT 2021

REPOSITORIES: GNPS

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
		Other

Items per page:

1 - 1 of 1

Similar Datasets

Epigenomic analysis of human advanced heart failure

Project description:Epigenomic analysis of human advanced heart failure

| PRJNA1322538 | ENA

Advanced Genetic and Molecular Analysis of Solid Tumors

Project description:Advanced Genetic and Molecular Analysis of Solid Tumors

| PRJNA615692 | ENA

Advanced Genetic and Molecular Analysis of Solid Tumors

Project description:Advanced Genetic and Molecular Analysis of Solid Tumors

| PRJNA615693 | ENA

Mild vs advanced liver fibrosis

Project description:The aim of this study is to compare mild and advanced liver fibrosis gene expression profiling and to identify novel markers of fibrosis progression. By transcriptome analysis with a cDNA array virtually covering every transcript in liver, we compared transcript levels in mild (F1 Metavir score) and advanced (F4 Metavir score) fibrosis. A stringent selection identified a list of 16 transcripts which completely separated the 2 groups of patients (8 F1 and 8 F4). We report that dysregulations at the transcriptional level do exist between mild fibrosis (F1) and advanced fibrosis (F4). Keywords: fibrosis stage-dependent analysis Fibrosis samples were analyzed for 16 patients : 8 mild fibrosis (F1-1 to F1-8) and 8 advanced fibrosis (F4-1 to F4-8). All data in the current study were obtained from 3 separate hybridizations per RNA sample.

2008-05-24 | E-GEOD-11536 | biostudies-arrayexpress

Ultrasensitive circulating tumor DNA analysis in locally advanced esophageal cancer

Project description:Ultrasensitive circulating tumor DNA analysis in locally advanced esophageal cancer

| PRJNA1443359 | ENA

Transcriptome analysis the early and advanced stage of ovarian cancer

Project description:Transcriptome analysis the early and advanced stage of ovarian cancer

| PRJNA675113 | ENA

Ultrasensitive circulating tumor DNA analysis in locally advanced esophageal cancer

Project description:Ultrasensitive circulating tumor DNA analysis in locally advanced esophageal cancer

| PRJNA1443358 | ENA

Rat hepatocytes: Advanced cirrhosis vs Control liver, Advanced cirrhosis vs Early cirrhosis

Project description:Gene profiling of hepatocytes in early and advanced cirrhotic Rats Two-condition experiment, Advanced cirrhosis vs Control liver, Advanced cirrhosis vs Early cirrhosis. Biological replicates: 5 Advanced cirrhosis, 5 Early cirrhosis, 5 control liver. Each hepatocyte was isolated independently. One replicate per array.

2011-11-02 | E-GEOD-22977 | biostudies-arrayexpress

Proteomic analysis of advanced clear cell renal cell carcinoma

Project description:Clear cell renal cell carcinoma (ccRCC) is the most common type of kidney cancer. Advanced kidney cancer has a high chance of recurrence and metastasis after surgery. This project performed proteomic analysis on advanced ccRCC tumor samples to describe the molecular landscape of advanced tumors.

2025-01-02 | PXD059367 |

Serial gene expression analysis in locally advanced breast cancer patients who failed to respond to neoadjuvant chemotherapy

Project description:To elucidate candidate genes and pathways associated with poor response, we retrospectively analyzed gene expression profiles in serial biopsies from women with locally advanced breast cancer who failed to respond to anthracycline-based chemo followed by taxane in the I-SPY Of the 221 patients who completed neoadjuvant chemotherapy, 215 patients had surgery with 73% not achieving a pathologic complete response (pathCR). In these patients, cDNA microarray expression profiles from pretreatment biopsy (T1) were compared to those biopsy specimens obtained 24-72 hours after initiation of treatment (T2) or in tumors surgically removed after chemotherapy (TS). Paired expression data for T1vsT2 and T1vsTS were available for 29 and 39 patients with no pathCR, respectively. Paired differential expression analyses were performed via Significance Analysis of Microarrays (SAM) and differentially expressed genes were subjected to Ingenuity Pathway Analysis

2015-06-12 | E-GEOD-32603 | biostudies-arrayexpress

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data